In a Medscape review on type 2 diabetes remission, AACE President Scott D. Isaacs, MD, FACP, FACE, emphasized that remission is not the same as reversal and highlighted growing evidence that…
The long‑awaited results of SURPASS‑CVOT were recently published in the New England Journal of Medicine, marking a major advance in the evidence base for incretin‑based therapy for patients…
The weight loss medication Wegovy is now available as a pill. In an NPR report, AACE Past President Scott D. Isaacs, MD, FACP, FACE, emphasizes the importance of careful patient education, noting…
If your blood sugar is on the rise, it’s not just a diabetes risk. AACE President Dace L. Trence, MD, MACE, emphasizes that prediabetes can raise cardiovascular risk by driving inflammation and…
Even if your blood sugar is usually well managed, unexpected fluctuations can happen during illness, injury, or recovery, especially when your immune system is under stress. AACE Past President Scott…
The American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Management of Adults with Type 2 Diabetes - 2026 Update provides evidence-based visual guidance and key…
The first AACE diabetes management algorithm was introduced in 2009, and the new 2026 AACE Algorithm for Management of Adults With Type 2 Diabetes moves into the era of modern, evidence-based,…
narrow therapeutic index (NTI), even small changes in dose, timing, or formulation can affect how you feel. This resource will help you understand why consistency matters…
Learn about the key updates in the 2026 AACE Type 2 Diabetes Algorithm, including a new diabetes classification tool and the recognition of MASLD as a comorbidity for the first time. AACE Task Force…
The theme of the upcoming American Association of Clinical Endocrinology (AACE) Annual Meeting 2026 in Las Vegas is "Viva Nutrition! Advancing Endocrine Practice From the Inside Out." AACE President…